Showing results (21-30 of 1,083) with videos related to
Sort By:
Pageof 109
JACC. Cardiovascular Interventions|January 4, 2023
Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCIDavide Capodanno, Dominick J AngiolilloThrombosis and Haemostasis|July 24, 2015
Management of adjunctive antithrombotic therapy in STEMI patients treated with fibrinolysis undergoing rescue or delayed PCIDavide Capodanno, Dominick J AngiolilloInterventional Cardiology Clinics|November 26, 2016
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs?Davide Capodanno, Dominick J AngiolilloJACC. Cardiovascular Interventions|April 7, 2021
Antithrombotic Management of Elderly Patients With Coronary Artery DiseasePiera Capranzano, Dominick J AngiolilloCirculation|November 30, 2020
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes MellitusDavide Capodanno, Dominick J AngiolilloInterventional Cardiology Clinics|June 6, 2017
Basics of Antithrombotic Therapy for Cardiovascular Disease: Pharmacologic Targets of Platelet Inhibitors and AnticoagulantsPiera Capranzano, Dominick J AngiolilloExpert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J AngiolilloThe American Journal of Cardiology|March 12, 2021
Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the EvidenceDominick J Angiolillo, Davide CapodannoFrontiers in Cardiovascular Medicine|September 12, 2022
De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?Mattia Galli, Dominick J AngiolilloItalian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|December 11, 2003
[Past, present, and future of intracoronary brachytherapy]Dominick J Angiolillo, Manel SabatéPageof 109